Key Details
Price
$6.53Annual ROE
-36.36%Beta
1.94Events Calendar
Next earnings date:
May 15, 2025Recent quarterly earnings:
Nov 5, 2024Recent annual earnings:
Feb 27, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Feb 28, 25 HC Wainwright & Co.
BuyNov 6, 24 RBC Capital
OutperformNov 6, 24 HC Wainwright & Co.
BuyNov 6, 24 Canaccord Genuity
BuyAug 12, 24 HC Wainwright & Co.
BuyAug 12, 24 Canaccord Genuity
BuyAug 9, 24 RBC Capital
OutperformMay 9, 24 HC Wainwright & Co.
BuyApr 3, 24 Stifel
BuyFeb 28, 24 RBC Capital
OutperformMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Verve Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Verve Therapeutics?
- Does Verve Therapeutics pay dividends?
- What sector is Verve Therapeutics in?
- What industry is Verve Therapeutics in?
- What country is Verve Therapeutics based in?
- When did Verve Therapeutics go public?
- Is Verve Therapeutics in the S&P 500?
- Is Verve Therapeutics in the NASDAQ 100?
- Is Verve Therapeutics in the Dow Jones?
- When was Verve Therapeutics's last earnings report?
- When does Verve Therapeutics report earnings?
- Should I buy Verve Therapeutics stock now?
What is the ticker symbol for Verve Therapeutics?
The ticker symbol for Verve Therapeutics is NASDAQ:VERV
Does Verve Therapeutics pay dividends?
No, Verve Therapeutics does not pay dividends
What sector is Verve Therapeutics in?
Verve Therapeutics is in the Healthcare sector
What industry is Verve Therapeutics in?
Verve Therapeutics is in the Biotechnology industry
What country is Verve Therapeutics based in?
Verve Therapeutics is headquartered in United States
When did Verve Therapeutics go public?
Verve Therapeutics's initial public offering (IPO) was on June 17, 2021
Is Verve Therapeutics in the S&P 500?
No, Verve Therapeutics is not included in the S&P 500 index
Is Verve Therapeutics in the NASDAQ 100?
No, Verve Therapeutics is not included in the NASDAQ 100 index
Is Verve Therapeutics in the Dow Jones?
No, Verve Therapeutics is not included in the Dow Jones index
When was Verve Therapeutics's last earnings report?
Verve Therapeutics's most recent earnings report was on Nov 5, 2024
When does Verve Therapeutics report earnings?
The next expected earnings date for Verve Therapeutics is May 15, 2025
Should I buy Verve Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions